These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3677422

  • 1. Determination of erythrocyte porphobilinogen deaminase activity using porphobilinogen as substrate.
    Hsiao KJ, Lee FY, Wu SJ, Chang WJ.
    Clin Chim Acta; 1987 Sep 30; 168(2):257-8. PubMed ID: 3677422
    [No Abstract] [Full Text] [Related]

  • 2. Assay for erythrocyte uroporphyrinogen I synthase activity, with porphobilinogen as substrate.
    Ford RE, Ou CN, Ellefson RD.
    Clin Chem; 1980 Jul 30; 26(8):1182-5. PubMed ID: 7389090
    [Abstract] [Full Text] [Related]

  • 3. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E, Gregor A.
    Ann Clin Res; 1986 Jul 30; 18(4):195-8. PubMed ID: 3789651
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of effect of pregnancy or hematin therapy on erythrocyte porphobilinogen deaminase activity in acute intermittent porphyria.
    Sassa S, Kappas A.
    N Engl J Med; 1989 Jul 20; 321(3):192-3. PubMed ID: 2747754
    [No Abstract] [Full Text] [Related]

  • 6. Erythrocyte porphobilinogen deaminase activity in liver diseases and proliferative diseases of the haemopoietic system and lymph nodes.
    Ostrowski J, Lutyński A, Cianciara J, Martyńska M, Kostrzewska E, Butruk E.
    Mater Med Pol; 1987 Jul 20; 19(4):234-7. PubMed ID: 3454831
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL, McColl KE, Moore MR, Brodie MJ, Adamson AR, Goldberg A.
    Br J Clin Pharmacol; 1989 Apr 20; 27(4):491-7. PubMed ID: 2497768
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Porphyrin biosynthesis and enzymatic studies in erythrocytes from normals and porphyric humans.
    Parera VE, Stella AM, Wider de Xifra EA, Fukuda H, Batlle AM.
    Int J Biochem; 1980 Apr 20; 12(5-6):947-53. PubMed ID: 7450154
    [No Abstract] [Full Text] [Related]

  • 17. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
    Pierach CA, Weimer MK, Cardinal RA, Bossenmaier IC, Bloomer JR.
    JAMA; 1987 Jan 02; 257(1):60-1. PubMed ID: 3783903
    [Abstract] [Full Text] [Related]

  • 18. Immunological determination of porphobilinogen deaminase as a diagnostic measure in acute intermittent porphyria.
    Lannfelt L.
    J Clin Chem Clin Biochem; 1990 May 02; 28(5):273-8. PubMed ID: 2380662
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.